search
Back to results

Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"

Primary Purpose

Respiratory Distress Syndrome, Intraventricular Hemorrhage, Neonatal Mortality

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Betamethasone(Celestone soluspan) and Dexamethasone
Sponsored by
University of Oklahoma
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Distress Syndrome focused on measuring Antenatal corticosteroids, Betamethasone, Dexamethasone, Premature

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women in preterm labor with intact membranes
  • Women with preterm premature rupture of membranes
  • Women been delivered for fetal and maternal indications
  • Gestational age between 24 and 33 6/7 weeks'.

Exclusion Criteria:

  • Clinical chorioamnionitis
  • known major fetal structural anomalies,
  • known fetal chromosomal abnormalities,
  • prior antenatal steroid exposure,
  • quadruplets and higher order multiple gestation
  • Women who declined enrollment.

Sites / Locations

  • Stony Brook University Hospital

Outcomes

Primary Outcome Measures

Respiratory distress syndrome
Intraventricular hemorrhage
Neonatal mortality

Secondary Outcome Measures

Periventricular leukomalacia
Necrotizing enterocolitis
Neonatal sepsis

Full Information

First Posted
January 2, 2007
Last Updated
January 2, 2007
Sponsor
University of Oklahoma
Collaborators
Stony Brook University
search

1. Study Identification

Unique Protocol Identification Number
NCT00418353
Brief Title
Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"
Study Type
Interventional

2. Study Status

Record Verification Date
January 2007
Overall Recruitment Status
Completed
Study Start Date
August 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University of Oklahoma
Collaborators
Stony Brook University

4. Oversight

5. Study Description

Brief Summary
Antenatal corticosteroids result in substantial decrease in neonatal morbidity and mortality by specifically reducing the risk of respiratory distress syndrome, intraventricular hemorrhage and neonatal death among premature infants. No human randomized study has formally compared betamethasone and dexamethasone, the preferred corticosteroids for antenatal therapy, with regards to their effectiveness in reducing neonatal morbidities and mortality. Our objective was to compare betamethasone with dexamethasone in terms of effectiveness in reducing perinatal morbidities and mortality among preterm infants.
Detailed Description
We conducted a double blind placebo-controlled randomized trial of antenatal betamethasone compared to dexamethasone among women at risk of preterm deliveries at Stony Brook University Hospital from August 1, 2002 through July 31, 2004. We excluded women with clinical chorioamnionitis, major fetal structural anomalies, fetal chromosomal abnormalities, prior antenatal steroid exposure, and use of betamethasone or dexamethasone for other medical indications, quadruplets and higher order multiple gestation and those who declined enrollment. Consenting women were randomly allocated to one of two groups by the Pharmacy using computer generated random numbers. The statistical analysis was performed in accordance of the intention-to-treat principle. Student t test, Chi square and Fisher exact test were used for analysis. A P value of < .05 was considered statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome, Intraventricular Hemorrhage, Neonatal Mortality
Keywords
Antenatal corticosteroids, Betamethasone, Dexamethasone, Premature

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Betamethasone(Celestone soluspan) and Dexamethasone
Primary Outcome Measure Information:
Title
Respiratory distress syndrome
Title
Intraventricular hemorrhage
Title
Neonatal mortality
Secondary Outcome Measure Information:
Title
Periventricular leukomalacia
Title
Necrotizing enterocolitis
Title
Neonatal sepsis

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women in preterm labor with intact membranes Women with preterm premature rupture of membranes Women been delivered for fetal and maternal indications Gestational age between 24 and 33 6/7 weeks'. Exclusion Criteria: Clinical chorioamnionitis known major fetal structural anomalies, known fetal chromosomal abnormalities, prior antenatal steroid exposure, quadruplets and higher order multiple gestation Women who declined enrollment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew A Elimian, M.D
Organizational Affiliation
Stony Brook University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stony Brook University Hospital
City
Stony Brook
State/Province
New York
ZIP/Postal Code
117913
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17601892
Citation
Elimian A, Garry D, Figueroa R, Spitzer A, Wiencek V, Quirk JG. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet Gynecol. 2007 Jul;110(1):26-30. doi: 10.1097/01.AOG.0000268281.36788.81.
Results Reference
derived

Learn more about this trial

Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"

We'll reach out to this number within 24 hrs